MedTrace Logo

A Model of Hospital-Territory Management Coordinated by a Case Manager to Improve the Care of Patients With Parkinsonism.

NCT05273957 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2024-03-25

No results posted yet for this study

Summary

The present multicenter randomized study investigates whether the management of patients with parkinsonism by a nurse specialist (case-manager) can significantly improve patients' quality of life over 12 months, compared to control patients managed with the standard-of-care process.

Participants will be evaluated with clinical scales testing quality of life, motor and non-motor symptoms, and the number of unscheduled hospital access throughout the course of the study.

Conditions

  • Parkinson Disease
  • Atypical Parkinsonism
  • Secondary Parkinsonism
  • Nurse-Patient Relations
  • Nurse Physician Relations

Interventions

OTHER

Case Manager

Patients are followed up by a nurse specialist in parkinsonism (case manager) who interacts with the treating neurologist and a multidisciplinary team

OTHER

Standard-of-care

Patients are managed only by the neurologist according the institution's clinical practice

Sponsors & Collaborators

  • Azienda Socio Sanitaria Territoriale Nord Milano

    collaborator UNKNOWN

  • Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

    lead OTHER

Principal Investigators

  • Roberto Eleopra, MD · Fondazione IRCCS Istituto Neurologico Carlo Besta

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-29
Primary Completion
2025-01-30
Completion
2025-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05273957 on ClinicalTrials.gov